Approval of migraine medications, including Emgality and Aimovigis, are subject to Alberta Blue Cross Special Authorization criteria. Patients must request that their specialist (i.e. neurologist) complete the Special Authorization form and submit it directly to Alberta Blue Cross for review and approval. ASEBP doesn’t need to review or receive copies of Special Authorization forms. See the Drug Inquiry Tool* on My ASEBP for eligibility details on specific drugs.
Enhanced Plan: 100%
Core Plan:
* If you are age 65 or older and live in Alberta, please read ASEBP’s response to the Government of Alberta’s Health Statutes Amendment Act to learn how to navigate the Interactive Drug Data Base (iDBL) to search your prescription drugs.

Allendale Centre East
Suite 301, 6104-104 Street NW
Edmonton, AB T6H 2K7